As the CD47 Targeting Therapeutics Market gains momentum, experts underscore an array of trends that are shaping its trajectory. The market is expected to expand dramatically, with projections indicating a rise to USD 23.3 billion by 2035, reflecting a compound annual growth rate (CAGR) of 22.89%. The increasing prevalence of cancer, particularly with over 1.9 million new cases documented in...